Valuation : PharmaEssentia Corporation

Market Cap 557B 17.69B 15.22B 14.33B 13.06B 24.44B 1,683B 24.53B 170B 65.66B 858B 66.43B 64.99B 2,717B P/E 2026 *
50.7x
P/E 2027 * 31.9x
Enterprise Value 531B 16.85B 14.5B 13.65B 12.44B 23.27B 1,603B 23.37B 162B 62.54B 817B 63.27B 61.9B 2,588B EV / Sales 2026 *
18.7x
EV / Sales 2027 * 13x
Free-Float
77.98%
Yield 2026 *
0.3%
Yield 2027 * 0.17%
1 day-4.27%
1 week+3.07%
Current month-3.58%
1 month+8.47%
3 months+50.70%
6 months+123.68%
Current year+217.44%
1 week 1,285
Extreme 1285
1,450
1 month 1,280
Extreme 1280
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
-4.27%+3.07%+211.22%+362.48% 18.47B
-0.94%-0.71%+45.60%+103.25% 69.19B
-0.07%-3.93%+32.54%+78.50% 62.97B
+3.13%+1.71%-12.50%+390.48% 27.27B
-2.91%-6.55%+26.01%+10.96% 25.8B
-0.54%-5.47%-3.88%-18.31% 24.78B
-1.43%-1.89%+21.32%-19.01% 20.11B
-0.96%-4.15%-4.86%+509.73% 14.88B
+1.14%-0.34%+52.38%+163.82% 14.29B
+1.50%+20.14%-6.83%+1,038.96% 13.79B
Average -0.55%+1.49%+36.10%+262.09% 29.15B
Weighted average by Cap. -0.55%-0.22%+35.50%+182.22%

Financials

2026 *2027 *
Net sales 28.33B 899M 774M 728M 664M 1.24B 85.56B 1.25B 8.63B 3.34B 43.59B 3.38B 3.3B 138B 40.06B 1.27B 1.09B 1.03B 939M 1.76B 121B 1.76B 12.21B 4.72B 61.64B 4.77B 4.67B 195B
Net income 11.02B 350M 301M 283M 258M 483M 33.29B 485M 3.36B 1.3B 16.96B 1.31B 1.29B 53.72B 17.69B 561M 483M 455M 415M 776M 53.43B 779M 5.39B 2.08B 27.22B 2.11B 2.06B 86.23B
Net Debt -26.52B -842M -724M -682M -622M -1.16B -80.11B -1.17B -8.08B -3.12B -40.81B -3.16B -3.09B -129B -34.73B -1.1B -948M -893M -814M -1.52B -105B -1.53B -10.58B -4.09B -53.43B -4.14B -4.05B -169B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-09-09 NT$1,345.00 -4.27% 4,564,007
26-09-08 NT$1,405.00 +6.04% 4,860,872
26-09-07 NT$1,325.00 +1.15% 4,821,947
26-09-04 NT$1,310.00 -2.96% 3,488,695
26-09-03 NT$1,350.00 +3.45% 3,196,968
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,345.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+3.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!